ATE314076T1 - Fosinopril-formulierung - Google Patents

Fosinopril-formulierung

Info

Publication number: ATE314076T1
Authority: AT; Austria
Prior art keywords: fosinopril; formulation; fosinoprilat; ace; prodrug
Prior art date: 2002-03-19

Application number

AT03706893T

Other languages

English (en)

Inventor

Reynir Eyjolfsson

Original Assignee

Actavis Group Hf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-19

Filing date

2003-03-19

Publication date

2006-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36715398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE314076(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-03-19 Application filed by Actavis Group Hf filed Critical Actavis Group Hf

2006-01-15 Application granted granted Critical

2006-01-15 Publication of ATE314076T1 publication Critical patent/ATE314076T1/de

Links

BIDNLKIUORFRQP-XYGFDPSESA-N (2s,4s)-4-cyclohexyl-1-[2-[[(1s)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([P@@](=O)(O[C@H](OC(=O)CC)C(C)C)CC(=O)N1[C@@H](C[C@H](C1)C1CCCCC1)C(O)=O)CCCC1=CC=CC=C1 BIDNLKIUORFRQP-XYGFDPSESA-N 0.000 title abstract 3
238000009472 formulation Methods 0.000 title abstract 3
229960002490 fosinopril Drugs 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 3
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract 1
BYNVYIUJKRRNNC-UHFFFAOYSA-N docosanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCCCCCC(O)=O BYNVYIUJKRRNNC-UHFFFAOYSA-N 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
WOIWWYDXDVSWAZ-RTWAWAEBSA-N fosinoprilat Chemical compound C([C@@H](C[C@H]1C(=O)O)C2CCCCC2)N1C(=O)CP(O)(=O)CCCCC1=CC=CC=C1 WOIWWYDXDVSWAZ-RTWAWAEBSA-N 0.000 abstract 1
229960003018 fosinoprilat Drugs 0.000 abstract 1
239000000314 lubricant Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT03706893T 2002-03-19 2003-03-19 Fosinopril-formulierung ATE314076T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IS6315A IS1935B (is)	2002-03-19	2002-03-19	Fósínópríl lyfjasamsetning
PCT/IS2003/000013 WO2003077929A1 (en)	2002-03-19	2003-03-19	Fosinopril formulation

Publications (1)

Publication Number	Publication Date
ATE314076T1 true ATE314076T1 (de)	2006-01-15

Family

ID=36715398

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03706893T ATE314076T1 (de)	2002-03-19	2003-03-19	Fosinopril-formulierung

Country Status (13)

Country	Link
US (1)	US7045511B2 (de)
EP (1)	EP1531831B1 (de)
AT (1)	ATE314076T1 (de)
AU (1)	AU2003208599A1 (de)
DE (1)	DE60303041T2 (de)
DK (1)	DK1531831T3 (de)
EA (1)	EA008171B1 (de)
ES (1)	ES2256721T3 (de)
IS (1)	IS1935B (de)
NO (1)	NO20044390L (de)
PT (1)	PT1531831E (de)
UA (1)	UA78988C2 (de)
WO (1)	WO2003077929A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1635792T3 (da) *	2003-06-26	2009-06-15	Teva Pharma	Stabile farmaceutiske sammensætninger af 2-aza-bicyklo-3.3.0-oktan-3-carboxylsyrederivater
US20050095287A1 (en) *	2003-10-29	2005-05-05	Matharu Amol S.	Fosinopril composition
GB2411355B (en)	2004-02-27	2006-02-22	Niche Generics Ltd	Pharmaceutical composition
BRPI0608238A2 (pt) *	2005-02-11	2009-11-24	Aventis Pharma Inc	ésteres do ácido propano fosfìnico substituìdo
WO2006100602A2 (en) *	2005-03-22	2006-09-28	Aurobindo Pharma Ltd	Immediate release stable solid oral dosage forms op fosinopril
RU2008145115A (ru) *	2006-04-19	2010-05-27	Тева Фармасьютикл Индастриес Лтд. (Il)	Стабильные фармацевтические композиции производственных соединений 2-аза-бицикло[3.3.0]-октан-3-карбоновой кислоты
GB0612540D0 (en) *	2006-06-23	2006-08-02	Novartis Ag	Galenical formulations of organic compounds
ES2313578T3 (es) *	2006-07-10	2009-03-01	Teva Pharmaceutical Industries Ltd	Formulacion estable que comprende una combinacion de un farmaco sensible a la humedad y un segundo farmaco y procedimiento de preparacion de la misma.
US20140179712A1 (en)	2012-12-21	2014-06-26	Astrazeneca Ab	Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4337201A (en) *	1980-12-04	1982-06-29	E. R. Squibb & Sons, Inc.	Phosphinylalkanoyl substituted prolines
US5006344A (en) *	1989-07-10	1991-04-09	E. R. Squibb & Sons, Inc.	Fosinopril tablet formulations
US6521647B2 (en) *	2000-04-04	2003-02-18	Pfizer Inc.	Treatment of renal disorders
CA2330904C (en) *	2001-01-11	2006-10-24	Bernard Charles Sherman	Fosinopril sodium tablet formulation
KR20040053210A (ko) *	2001-11-02	2004-06-23	화이자 프로덕츠 인크.	Ｐｄｅ9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
ITMI20012366A1 (it) *	2001-11-09	2003-05-09	Farmatron Ltd	Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali

2002
- 2002-03-19 IS IS6315A patent/IS1935B/is unknown
2003
- 2003-03-19 AT AT03706893T patent/ATE314076T1/de active
- 2003-03-19 EA EA200401218A patent/EA008171B1/ru not_active IP Right Cessation
- 2003-03-19 AU AU2003208599A patent/AU2003208599A1/en not_active Abandoned
- 2003-03-19 US US10/507,918 patent/US7045511B2/en not_active Expired - Fee Related
- 2003-03-19 DK DK03706893T patent/DK1531831T3/da active
- 2003-03-19 UA UA20041008392A patent/UA78988C2/uk unknown
- 2003-03-19 EP EP03706893A patent/EP1531831B1/de not_active Expired - Lifetime
- 2003-03-19 ES ES03706893T patent/ES2256721T3/es not_active Expired - Lifetime
- 2003-03-19 DE DE60303041T patent/DE60303041T2/de not_active Expired - Lifetime
- 2003-03-19 WO PCT/IS2003/000013 patent/WO2003077929A1/en not_active Ceased
- 2003-03-19 PT PT03706893T patent/PT1531831E/pt unknown
2004
- 2004-10-18 NO NO20044390A patent/NO20044390L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PT1531831E (pt)	2006-05-31
EP1531831B1 (de)	2005-12-28
IS1935B (is)	2004-06-16
DK1531831T3 (da)	2006-05-15
AU2003208599A1 (en)	2003-09-29
EA008171B1 (ru)	2007-04-27
DE60303041D1 (de)	2006-02-02
IS6315A (is)	2003-09-20
WO2003077929A1 (en)	2003-09-25
US7045511B2 (en)	2006-05-16
DE60303041T2 (de)	2006-08-24
NO20044390L (no)	2004-12-15
UA78988C2 (en)	2007-05-10
US20050256086A1 (en)	2005-11-17
EA200401218A1 (ru)	2005-12-29
EP1531831A1 (de)	2005-05-25
ES2256721T3 (es)	2006-07-16

Legal Events

Date

Code

Title

Description

2006-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1531831

Country of ref document: EP

Publication	Publication Date	Title
NO20043367L (no)	2004-08-13	Oralt farmasoytisk preparat
CY1109457T1 (el)	2014-08-13	Παραγωγο aminoαλκοολης ή παραγωγο φωσφονικου οξεος και φαρμακευτικη συνθεση που τα περιεχει
BR0209431A (pt)	2004-08-03	Novos compostos de 4-anilinoquinolino-3-carboxamidas
MXPA04004464A (es)	2004-08-11	Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
MA29857B1 (fr)	2008-10-03	Derives de triazolopyridine en tant qu'inhibiteurs de lipases et phospholipases
NO20081050L (no)	2008-04-28	Kaspaseinhibitor-prodroger
SG10201809390QA (en)	2018-11-29	Modulators of indoleamine 2,3-dioxygenase and methods of using the same
MA29858B1 (fr)	2008-10-03	Derives de carbamoylbenzotriazole en tant qu'inhibiteurs de lipases et phospholipases
EA200501268A1 (ru)	2006-02-24	Ингибирующие вич 1,2,4-триазины
NO20060847L (no)	2006-02-21	Substituert 2-aminotetralin til behandling av depresjon
ATE554084T1 (de)	2012-05-15	N-hydroxyacrylamidverbindungen
MX2009003926A (es)	2009-06-26	Composiciones de fenilalquilamino-carbamato.
UY30426A1 (es)	2008-01-31	Derivados sustituidos del 3-(4-metoxi-fenil)-3h-isoindol-1-ilamina trifluoroacetado, sus sales o solvatos farmaceuticamente aceptables, formulaciones farmacéuticas y aplicaciones.
TW200621313A (en)	2006-07-01	Pharmaceutical compositions
DE602004008959D1 (de)	2007-10-25	Benzoäbüä1,4üdioxepinderivate
MX2009003929A (es)	2009-06-26	Composiciones de fenilalquil carbamato.
MXPA04006266A (es)	2004-09-27	Pirimidotriazinas como inhibidores de fosfatasa.
DK1531831T3 (da)	2006-05-15	Fosinoprilformulering
BR0112245B1 (pt)	2013-09-10	Éster de ácido 4-alcóxi-ciclohexano-1-amino-carboxílico
EA200601608A1 (ru)	2007-02-27	Способ производства твёрдой фармацевтической композиции
NO20083183L (no)	2008-09-26	Fast farmasoytisk sammensetning inneholdende irbesartan
WO2008036316A3 (en)	2008-11-06	Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
MXPA05013012A (es)	2006-03-02	Formulaciones blanqueadoras fluorescentes estables al almacenamiento.
MXPA06000636A (es)	2006-04-19	Formulaciones semi-solidas para la administracion oral de taxoides.
TNSN06012A1 (en)	2007-10-03	Emulsifying systems containing azetidine derivatives